 Erica Wymore
Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Marijuana Use | 9 | 2025 | 192 | 3.100 |
Why?
| | Dronabinol | 7 | 2025 | 203 | 2.010 |
Why?
| | Neonatal Abstinence Syndrome | 3 | 2025 | 23 | 1.520 |
Why?
| | Bronchopulmonary Dysplasia | 8 | 2024 | 378 | 1.500 |
Why?
| | Cannabis | 6 | 2025 | 462 | 1.460 |
Why?
| | Infant, Premature | 9 | 2024 | 541 | 1.250 |
Why?
| | Pregnancy Complications | 5 | 2025 | 494 | 1.160 |
Why?
| | Lactation | 2 | 2025 | 175 | 1.050 |
Why?
| | Gestational Age | 11 | 2024 | 876 | 1.030 |
Why?
| | Retinopathy of Prematurity | 7 | 2024 | 140 | 1.010 |
Why?
| | Infant, Newborn | 26 | 2025 | 5772 | 0.900 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2025 | 573 | 0.840 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2024 | 67 | 0.820 |
Why?
| | Milk, Human | 2 | 2021 | 151 | 0.800 |
Why?
| | Opiate Alkaloids | 1 | 2020 | 6 | 0.690 |
Why?
| | Birth Weight | 6 | 2024 | 505 | 0.660 |
Why?
| | Infant, Small for Gestational Age | 2 | 2019 | 84 | 0.640 |
Why?
| | Intensive Care Units, Neonatal | 4 | 2021 | 228 | 0.610 |
Why?
| | Marijuana Abuse | 1 | 2019 | 233 | 0.530 |
Why?
| | Pregnancy | 13 | 2025 | 6423 | 0.520 |
Why?
| | Neonatal Screening | 3 | 2025 | 163 | 0.460 |
Why?
| | Substance-Related Disorders | 1 | 2023 | 1023 | 0.460 |
Why?
| | Breast Feeding | 4 | 2025 | 424 | 0.410 |
Why?
| | Colorado | 10 | 2024 | 4410 | 0.400 |
Why?
| | Opioid-Related Disorders | 1 | 2019 | 484 | 0.390 |
Why?
| | Hospitals | 3 | 2023 | 649 | 0.300 |
Why?
| | Infant | 11 | 2024 | 9018 | 0.300 |
Why?
| | Infant, Low Birth Weight | 2 | 2019 | 134 | 0.280 |
Why?
| | Female | 23 | 2025 | 68829 | 0.270 |
Why?
| | Substance Abuse Detection | 2 | 2025 | 79 | 0.260 |
Why?
| | Humans | 34 | 2025 | 129847 | 0.260 |
Why?
| | Marijuana Smoking | 2 | 2019 | 247 | 0.250 |
Why?
| | Mothers | 2 | 2023 | 731 | 0.240 |
Why?
| | Tracheostomy | 2 | 2024 | 129 | 0.230 |
Why?
| | Ventilator Weaning | 1 | 2024 | 36 | 0.230 |
Why?
| | Hospital Mortality | 2 | 2019 | 852 | 0.230 |
Why?
| | Diseases in Twins | 1 | 2024 | 175 | 0.210 |
Why?
| | Infant, Very Low Birth Weight | 3 | 2019 | 67 | 0.210 |
Why?
| | Propofol | 1 | 2024 | 63 | 0.210 |
Why?
| | Twins | 1 | 2024 | 247 | 0.210 |
Why?
| | Cannabidiol | 1 | 2024 | 108 | 0.200 |
Why?
| | Respiration, Artificial | 2 | 2024 | 617 | 0.200 |
Why?
| | Cohort Studies | 6 | 2024 | 5444 | 0.200 |
Why?
| | Logistic Models | 3 | 2024 | 1989 | 0.200 |
Why?
| | Umbilical Cord | 2 | 2021 | 83 | 0.190 |
Why?
| | Analgesics, Opioid | 2 | 2020 | 925 | 0.190 |
Why?
| | Self Report | 3 | 2024 | 800 | 0.190 |
Why?
| | Pre-Eclampsia | 1 | 2024 | 187 | 0.180 |
Why?
| | Metabolism | 1 | 2021 | 38 | 0.180 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 40 | 0.180 |
Why?
| | Risk Factors | 7 | 2024 | 9801 | 0.180 |
Why?
| | Adult | 8 | 2025 | 35634 | 0.170 |
Why?
| | Severity of Illness Index | 3 | 2024 | 2739 | 0.170 |
Why?
| | Fetus | 1 | 2025 | 782 | 0.170 |
Why?
| | Algorithms | 2 | 2018 | 1617 | 0.170 |
Why?
| | Reference Standards | 1 | 2020 | 176 | 0.170 |
Why?
| | Ventricular Septum | 1 | 2019 | 8 | 0.160 |
Why?
| | Hospitalization | 2 | 2019 | 2079 | 0.160 |
Why?
| | Prenatal Care | 2 | 2019 | 277 | 0.160 |
Why?
| | Massachusetts | 1 | 2019 | 159 | 0.160 |
Why?
| | Interrupted Time Series Analysis | 1 | 2019 | 54 | 0.160 |
Why?
| | Cannabinoids | 1 | 2021 | 154 | 0.160 |
Why?
| | Pregnancy Outcome | 2 | 2019 | 392 | 0.150 |
Why?
| | Legislation, Drug | 1 | 2019 | 77 | 0.150 |
Why?
| | Enteral Nutrition | 2 | 2011 | 186 | 0.150 |
Why?
| | Infant, Newborn, Diseases | 1 | 2019 | 111 | 0.150 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 108 | 0.140 |
Why?
| | Abnormalities, Multiple | 1 | 2019 | 175 | 0.140 |
Why?
| | Male | 14 | 2024 | 63759 | 0.140 |
Why?
| | Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2016 | 6 | 0.130 |
Why?
| | Hyperammonemia | 1 | 2016 | 16 | 0.130 |
Why?
| | Cross-Sectional Studies | 3 | 2023 | 5085 | 0.130 |
Why?
| | Data Collection | 1 | 2019 | 653 | 0.130 |
Why?
| | Echocardiography | 1 | 2019 | 636 | 0.130 |
Why?
| | Risk-Taking | 1 | 2019 | 348 | 0.130 |
Why?
| | Adolescent | 5 | 2024 | 20451 | 0.130 |
Why?
| | Medical Marijuana | 1 | 2018 | 111 | 0.130 |
Why?
| | Vascular Malformations | 1 | 2016 | 51 | 0.130 |
Why?
| | Weight Gain | 1 | 2019 | 510 | 0.120 |
Why?
| | Portal Vein | 1 | 2016 | 108 | 0.120 |
Why?
| | Retrospective Studies | 10 | 2024 | 14553 | 0.120 |
Why?
| | Incidence | 2 | 2019 | 2646 | 0.120 |
Why?
| | Depression | 1 | 2024 | 1323 | 0.120 |
Why?
| | Length of Stay | 1 | 2020 | 1133 | 0.120 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2017 | 310 | 0.120 |
Why?
| | Medical Errors | 1 | 2016 | 108 | 0.110 |
Why?
| | Databases, Factual | 1 | 2019 | 1269 | 0.110 |
Why?
| | Young Adult | 5 | 2024 | 12467 | 0.110 |
Why?
| | Surgical Procedures, Operative | 1 | 2016 | 244 | 0.100 |
Why?
| | Heart Defects, Congenital | 2 | 2011 | 796 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 291 | 0.100 |
Why?
| | Blood Pressure | 1 | 2019 | 1736 | 0.100 |
Why?
| | Prospective Studies | 2 | 2021 | 7158 | 0.100 |
Why?
| | Quality Improvement | 1 | 2020 | 1112 | 0.100 |
Why?
| | Professional Practice | 1 | 2011 | 62 | 0.090 |
Why?
| | Prevalence | 3 | 2024 | 2564 | 0.080 |
Why?
| | Alprostadil | 1 | 2008 | 32 | 0.080 |
Why?
| | Child | 4 | 2021 | 20962 | 0.080 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2008 | 36 | 0.070 |
Why?
| | Liver | 1 | 2016 | 1839 | 0.070 |
Why?
| | ROC Curve | 2 | 2019 | 504 | 0.070 |
Why?
| | Hypertension, Pulmonary | 1 | 2018 | 1897 | 0.070 |
Why?
| | Vasodilator Agents | 1 | 2008 | 326 | 0.070 |
Why?
| | Preoperative Care | 1 | 2008 | 337 | 0.060 |
Why?
| | Anesthetics, Intravenous | 1 | 2024 | 46 | 0.050 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 78 | 0.050 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 49 | 0.050 |
Why?
| | Maternal-Fetal Exchange | 1 | 2025 | 162 | 0.050 |
Why?
| | Pediatrics | 1 | 2011 | 1074 | 0.050 |
Why?
| | Infusions, Intravenous | 1 | 2024 | 402 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2024 | 178 | 0.050 |
Why?
| | Analgesics | 1 | 2024 | 194 | 0.050 |
Why?
| | Pain, Postoperative | 1 | 2024 | 247 | 0.050 |
Why?
| | Limit of Detection | 1 | 2021 | 83 | 0.050 |
Why?
| | Diet, Ketogenic | 1 | 2021 | 37 | 0.040 |
Why?
| | Hospitals, Urban | 1 | 2021 | 135 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 3773 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2021 | 142 | 0.040 |
Why?
| | Canada | 1 | 2021 | 353 | 0.040 |
Why?
| | Child Development | 1 | 2024 | 459 | 0.040 |
Why?
| | Vitamins | 1 | 2021 | 173 | 0.040 |
Why?
| | Growth Charts | 1 | 2019 | 14 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2021 | 426 | 0.040 |
Why?
| | Heart Septal Defects, Ventricular | 1 | 2019 | 41 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 836 | 0.040 |
Why?
| | Risk Assessment | 2 | 2019 | 3269 | 0.040 |
Why?
| | Anthropometry | 1 | 2019 | 204 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 306 | 0.040 |
Why?
| | Nutritional Status | 1 | 2021 | 328 | 0.040 |
Why?
| | Intensive Care, Neonatal | 1 | 2018 | 40 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 528 | 0.040 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2018 | 38 | 0.040 |
Why?
| | Maternal Health Services | 1 | 2019 | 92 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2724 | 0.030 |
Why?
| | Lipids | 1 | 2021 | 628 | 0.030 |
Why?
| | North America | 1 | 2018 | 294 | 0.030 |
Why?
| | Laser Coagulation | 1 | 2017 | 57 | 0.030 |
Why?
| | Registries | 1 | 2024 | 1903 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2016 | 38 | 0.030 |
Why?
| | Autopsy | 1 | 2016 | 92 | 0.030 |
Why?
| | Acidosis, Lactic | 1 | 2016 | 46 | 0.030 |
Why?
| | Body Mass Index | 1 | 2024 | 2274 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 998 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2016 | 300 | 0.030 |
Why?
| | Urban Population | 1 | 2019 | 443 | 0.030 |
Why?
| | Glucose | 1 | 2021 | 1003 | 0.030 |
Why?
| | World Health Organization | 1 | 2016 | 110 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1501 | 0.030 |
Why?
| | Survival Rate | 1 | 2018 | 1872 | 0.030 |
Why?
| | Comorbidity | 1 | 2018 | 1551 | 0.030 |
Why?
| | Patient Readmission | 1 | 2018 | 668 | 0.030 |
Why?
| | Brain | 1 | 2025 | 2677 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1847 | 0.020 |
Why?
| | Models, Theoretical | 1 | 2016 | 549 | 0.020 |
Why?
| | Prostaglandins | 1 | 2011 | 94 | 0.020 |
Why?
| | Internationality | 1 | 2011 | 150 | 0.020 |
Why?
| | Child, Preschool | 1 | 2024 | 10522 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4896 | 0.020 |
Why?
| | Kidney Transplantation | 1 | 2016 | 670 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2011 | 558 | 0.020 |
Why?
| | Liver Transplantation | 1 | 2016 | 833 | 0.020 |
Why?
| | United States | 2 | 2017 | 13913 | 0.020 |
Why?
| | Internet | 1 | 2011 | 620 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2008 | 738 | 0.010 |
Why?
|
|
Wymore's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|